Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.56 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 10/20 | 0.54 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.51 |
| ▸ | BTK | Q06187 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29960290 | 1.00 | METAP2 (0.56) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL5025498 | 0.90 | CYP2A6 (0.49) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| 1-Propanethiol SCHEMBL5017380 | 0.87 | CYP2A6 (0.47) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| Butylamine SCHEMBL27685215 | 0.83 | CYP3A4 (0.47) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL12277978 | 0.80 | KDM4E (0.54) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| Niacinamide SCHEMBL28655386 | 0.79 | F7 (0.59) | SIRT3ALDH1A1LMNAMAPTHPGD | |
| SCHEMBL12278118 | 0.79 | CYP2A6 (0.44) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| Pyrimidine SCHEMBL28120108 | 0.78 | CYP1A2 (0.40) | METAP2SIRT3ALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL3507950 | 0.78 | BTK (0.47) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL14900162 | 0.78 | ALK (0.43) | METAP2SIRT3CYP3A4ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105682461-B | Pesticidal combination and relative method | 美国陶氏益农公司 | 2019-06-14 | — | — | CN | claimed |
| CN-103910763-B | Water-soluble iron complex and its preparation method and use | 苏州大学 | 2017-02-01 | — | — | CN | claimed |
| EP-3060046-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | Dow AgroSciences LLC (US) | 2016-08-31 | — | — | EP | claimed |
| CN-105682461-A | Pesticidal compositions and related methods | 美国陶氏益农公司 | 2016-06-15 | — | — | CN | claimed |
| WO-2015061161-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | DOW AGROSCIENCES LLC (US) | 2015-04-30 | — | — | WO | claimed |
| CN-101024660-B | Peroxo vanadium complex and its preparing method and crystal culture | UNIV HENAN SCIENCE & TECH | 2011-03-23 | — | — | CN | claimed |
| CN-101024653-B | 2-peroxo-vanadium-potassium salt complex, its preparing method and mono-crystal culture | UNIV HENAN SCIENCE & TECH | 2011-03-23 | — | — | CN | claimed |
| CN-101024660-A | Peroxo vanadium complex and its preparing method and culturation | HUNAN SCIENCE TECHNOLOGY UNIV (CN) | 2007-08-29 | — | — | CN | claimed |
| CN-101024653-A | 2-peroxo-vanadium-potassium salt complex, its preparing method and mono-crystal culturation | HUNAN SCIENCE TECHNOLOGY UNIV (CN) | 2007-08-29 | — | — | CN | claimed |
| US-20250388582-A1 | NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF | ILDONG PHARMACEUTICAL CO LTD (KR) | 2025-12-25 | — | — | US | disclosed |
| US-20250353851-A1 | PURINES AND METHODS OF THEIR USE | KINETA INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250288589-A1 | PYRIDOPYRIMIDINES AND METHODS OF THEIR USE | Kineta, Inc. | 2025-09-18 | — | — | US | disclosed |
| EP-4556476-A1 | NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF | Ildong Pharmaceutical Co., Ltd. (KR) | 2025-05-21 | — | — | EP | disclosed |
| CN-119708069-A | Bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-1998021199-A2 | PYRAZOLE DERIVATIVES USEFUL AS HERBICIDES | NOVARTIS AG (CH) | 1998-05-22 | — | — | WO | disclosed |
| WO-1994029300-A1 | PYRAZOLE FUNGICIDES 3-SUBSTITUTED BY A HETEROCYCLIC RING | RHONE POULENC AGROCHIMIE (FR) | 1994-12-22 | — | — | WO | disclosed |
| US-5227394-A | PYRAZOLE DERIVATIVES, COMPOSITIONS AND USE | AKZO N.V. (NL) | 1993-07-13 | — | — | US | disclosed |
| EP-0525879-A1 | Pyrazole derivatives | Akzo Nobel N.V. (NL) | 1993-02-03 | — | — | EP | disclosed |
| CN-85105299-A | The preparation method of cephem compounds | — | 1987-01-07 | — | — | CN | disclosed |
| EP-0160969-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250288589-A1 | PYRIDOPYRIMIDINES AND METHODS OF THEIR USE | PNPO, DPYD, PYGB | METAP2 246/4885SIRT3 918/4885CYP3A4 1035/4885 |
| US-20250388582-A1 | NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF | GBA1, PIKFYVE, MAN2B1 | METAP2 3499/4885SIRT3 3930/4885CYP3A4 4110/4885 |
| US-20250353851-A1 | PURINES AND METHODS OF THEIR USE | TDP1, TDP2, PIKFYVE | METAP2 2227/4885SIRT3 4346/4885CYP3A4 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.